Tumor Lysis Syndrome: A Practical Guide for Nurse Practitioners

被引：2
|
作者：
Ly, Thao-Tammy T. [1 ]
Winokur, Elizabeth J. [2 ]
机构：
[1] PIH Hlth, Whittier, CA 90602 USA
[2] St Joseph Hosp, Orange, CA USA
来源：
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2019年 / 15卷 / 09期
关键词：
cancer; electrolyte imbalances; hematologic cancer; oncologic emergency; tumor lysis syndrome; MANAGEMENT; EFFICACY; RASBURICASE; PREVENTION; FEBUXOSTAT; CHILDREN; ADULTS; RISK;
D O I：
10.1016/j.nurpra.2019.06.005
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Tumor lysis syndrome is an oncologic emergency that occurs when malignant cancer cells are lysed rapidly and the intracellular contents are released into the systemic circulation. It is most commonly seen in patients with hematologic cancers. The surge of electrolytes can cause renal failure, cardiac arrhythmias, seizures, and sudden death due to multiorgan failure. Tumor lysis syndrome can pose threatening complications. It is essential that nurse practitioners be prepared to monitor and treat prophylactically to prevent life-threatening consequences. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码：636 / 639
页数：4
相关论文
共 50 条
  • [1] Tumor Lysis Syndrome
    Williams, Shelly M.
    Killeen, Anthony A.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (03) : 386 - 393
  • [2] Spontaneous Tumor Lysis Syndrome
    Wesemueller, Wiebke
    Taverna, Christian
    CASE REPORTS IN ONCOLOGY, 2020, 13 (03): : 1116 - 1124
  • [3] Understanding tumor lysis syndrome
    Zafrani, Lara
    Canet, Emmanuel
    Darmon, Michael
    INTENSIVE CARE MEDICINE, 2019, 45 (11) : 1608 - 1611
  • [4] Diagnosis and management of tumor lysis syndrome
    Puri, Isha
    Sharma, Deep
    Gunturu, Krishna S.
    Ahmed, Andaleeb A.
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2020, 10 (03): : 269 - 272
  • [5] Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era
    Toda, Yumiko
    Ashizawa, Masahiro
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-Ichiro
    Nagayama, Takashi
    Umino, Kento
    Minakata, Daisuke
    Morita, Kaoru
    Yamamoto, Chihiro
    Hatano, Kaoru
    Sato, Kazuya
    Fujiwara, Shin-Ichiro
    Ohmine, Ken
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (06) : 660 - 666
  • [6] How I Treat Tumor Lysis Syndrome
    Joseph, Adrien
    Zafrani, Lara
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (12): : 1634 - 1636
  • [7] Reduced administration of rasburicase for tumor lysis syndrome: A single-institution experience
    Takai, Mihoko
    Yamauchi, Takahiro
    Matsuda, Yasufumi
    Tai, Katsunori
    Ikegaya, Satoshi
    Kishi, Shinji
    Urasaki, Yoshimasa
    Yoshida, Akira
    Iwasaki, Hiromichi
    Ueda, Takanori
    ONCOLOGY LETTERS, 2015, 9 (05) : 2119 - 2125
  • [8] Rasburicase in Tumor Lysis Syndrome of the Adult: A Systematic Review and Meta-analysis
    Lopez-Olivo, Maria A.
    Pratt, Gregory
    Palla, Shana L.
    Salahudeen, Abdulla
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (03) : 481 - 492
  • [9] Rasburicase in treating tumor lysis syndrome: An umbrella review
    Mahfooz, Kamran
    Sohail, Haris
    Gvajaia, Ani
    Arif, Uroosa
    Grewal, Daisy
    Muppidi, Monica Reddy
    Vohra, Vanya
    Tarique, Aamir
    Vasavada, Advait
    CANCER PATHOGENESIS AND THERAPY, 2023, 1 (04): : 262 - 271
  • [10] Current understanding of tumor lysis syndrome
    Rahmani, Benjamin
    Patel, Shrey
    Seyam, Omar
    Gandhi, Jason
    Reid, Inefta
    Smith, Noel
    Khan, Sardar Ali
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 537 - 547
12345